ELEKTA TO SUPPLY LEADING IGRT SOLUTION TO VEJLE HOSPITAL IN DENMARK

ELEKTA TO SUPPLY LEADING IGRT SOLUTION TO VEJLE HOSPITAL IN DENMARK

PRESS RELEASE
Stockholm, May 04, 2007

Vejle hospital has selected Elekta to supply world leading technology for
intensity modulated and image guided radiation therapy and two Elekta Synergy®
systems will be installed during 2007 and 2008. Elekta Synergy allows the
clinicians to visualize the target at the time of treatment, enabling more
aggressive treatment of tumors with increased precision and accuracy while
minimizing the risk of damage to surrounding healthy tissue. The order is valued
at over SEK 30 M.

Image guided radiation therapy (IGRT) has during the last couple of years become
standard for new deliveries of radiation therapy solutions and Elekta Synergy is
being established as the reference system for this more precise and accurate
method for radiating cancer tumors.
Vejle is a modern hospital in the southern part of Jutland. When it was time to
upgrade and increase treatment capacity at the oncology department, the hospital
evaluated available technology and found Elekta Synergy to best meet the highly
set criteria. Elekta Synergy makes it possible to precisely locate and position
the tumors inside the patient on a day-to-day basis, which is an important
advantage when treating many of the most common cancers such as prostate, breast
and lung cancer. Based on high-resolution 3D images, the necessary fine
adjustments are made in a matter of seconds while the patient is positioned in
the treatment system. 

“We have been working with Vejle hospital for many years and we are very pleased
that they chose a solution from Elekta when it came to taking the next step in
upgrading and expanding the hospital's radiation therapy facility. It's yet
another proof of Elekta's leading position in advanced clinical solutions for
cancer treatment and shows that Elekta can offer solutions that is very well
adapted to today's customer demand”, summarizes Lennart Ward, Ph.D., Business
Unit Manager Nordic & Baltic countries at Elekta.


********





For further information, please contact:

Peter Ejemyr
Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile)
e-mail: peter.ejemyr@elekta.com  
About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com.